Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools

June 2001
Journal of Neurology, Neurosurgery & Psychiatry;Jun2001, p711
Academic Journal
No abstract available.


Related Articles

  • Ready for Prime Time. Selkoe, Dennis J.; Morris, John C. // Scientist;Feb2012, Vol. 26 Issue 2, p26 

    The article offers information on the use of biomarkers in Alzheimer's disease (AD) diagnosis and monitoring. It says that contributors to the "Neurobilogy of Aging" periodical has concluded at least three AD biomarkers, such as structural magnetic resonance imaging (MRI), brain amyloid imaging,...

  • Magnetic resonance in the differential diagnosis of dementia. Felber, S. R. // Journal of Neural Transmission;Jul2002, Vol. 109 Issue 7/8, p1045 

    Summary. Magnetic resonance became an important tool for the differential diagnosis of dementia. Magnetic resonance imaging is the preferred method to exclude treatable entities accompagnied by dementing symptoms. New techniques including diffusion and perfusion magnetic resonance imaging are...

  • Evaluation of Cross-Protocol Stability of a Fully Automated Brain Multi-Atlas Parcellation Tool. Liang, Zifei; He, Xiaohai; Ceritoglu, Can; Tang, Xiaoying; Li, Yue; Kutten, Kwame S.; Oishi, Kenichi; Miller, Michael I.; Mori, Susumu; Faria, Andreia V. // PLoS ONE;7/24/2015, Vol. 10 Issue 7, p1 

    Brain parcellation tools based on multiple-atlas algorithms have recently emerged as a promising method with which to accurately define brain structures. When dealing with data from various sources, it is crucial that these tools are robust for many different imaging protocols. In this study, we...

  • Books and other media. Willmer, Jonathan // CMAJ: Canadian Medical Association Journal;04/01/97, Vol. 156 Issue 7, p1047 

    Reviews the book `Clinical Diagnosis and Management of Alzheimer's Disease,' edited by Serge Gauthier.

  • Radiopharmaceuticals for positron emission tomography investigations of Alzheimer’s disease. Någren, Kjell; Halldin, Christer; Rinne, Juha O. // European Journal of Nuclear Medicine & Molecular Imaging;Aug2010, Vol. 37 Issue 8, p1575 

    Alzheimer’s disease (AD) is a common degenerative neurological disease that is an increasing medical, economical, and social problem. There is evidence that a long “asymptomatic” phase of the disease exists where functional changes in the brain are present, but structural...

  • Dementia and ageing. Good, Catriona D. // British Medical Bulletin;Mar2003, Vol. 65 Issue 1, p159 

    Sophisticated imaging techniques are required to characterise the complex dynamic neuro-anatomical changes that occur over time in health and disease. With the advent of potential therapies for the treatment of degenerative dementias, imaging strategies need to enable early diagnosis and...

  • Neuroimaging in dementia: a practical guide. Mortimer, Alex M.; Likeman, Marcus; Lewis, Timothy L. // Practical Neurology (BMJ Publishing Group);Apr2013, Vol. 13 Issue 2, p92 

    Over 800 000 people in the UK are demented. Alzheimer's disease, dementia with Lewy bodies, vascular dementia and fronttemporal lobar degeneration account for the majority. Although detailed clinical assessment forms the basis of evaluating a patient with cognitive impairment, structural and...

  • An Overview of the Etiology, Diagnosis and Treatment of Alzheimer Disease. Forsyth, Elizabeth; Ritzline, Pamela D. // Physical Therapy;Dec1998, Vol. 78 Issue 12, p1325 

    Provides an overview of the etiology of Alzheimer Disease (AD), the tools used in the diagnosis of AD, and the treatment of individuals with AD. Description of the clinical presentation of the various stages of AD; Discussion on the psychosocial implications of the disease.

  • The Many Faces of Dementia. Shagam, Janet Yagoda // Radiologic Technology;Nov/Dec2009, Vol. 81 Issue 2, p153 

    Dementia is a progressive and incurable condition that in one way or another affects nearly everyone. Examples of specific types of dementia include Alzheimer disease, vascular dementia, frontotemporal dementia and dementia with Lewy bodies. Age is the primary risk factor for dementia and the...

  • RECENT ADVANCES IN THE MANAGEMENT OF ALZHEIMER'S DISEASE. K. CHANDRASHEKAR; VINAYAK METI; M. K. SARITHA // International Journal of Pharma & Bio Sciences;Jul-Sep2013, Vol. 4 Issue 3, pP-519 

    Alzheimer's disease is a disease of the elderly, mainly affecting people above 60 years of age. It is turning out to be a major public health problem with an estimated 4.7% of the population above 60 years of age (35.6 million) worldwide to be affected by dementia in 2010. The clinical diagnosis...


Read the Article


Sign out of this library

Other Topics